__NUXT_JSONP__("/drugs/Enfortumab_Vedotin", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[{brand:"PADCEV EJFV",indication:"1 INDICATIONS AND USAGE PADCEV ® is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer (mUC) who: • have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and platinum-containing chemotherapy, or • are ineligible for cisplatin-containing chemotherapy and have previously received one or more prior lines of therapy. PADCEV is a Nectin-4-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who: • have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and platinum-containing chemotherapy, or • are ineligible for cisplatin-containing chemotherapy and have previously received one or more prior lines of therapy. ( 1 )",manufacturer:"Seattle Genetics, Inc.",splSetId:"b5631d3e-4604-4363-8f20-11dfc5a4a8ed"}],id:a,nciThesaurus:{casRegistry:"1346452-25-2",chebiId:b,chemicalFormula:b,definition:"An antibody drug conjugate (ADC) containing a human monoclonal antibody AGS-22 targeting the cell adhesion molecule nectin-4 and conjugated to the cytotoxic agent monomethyl auristatin E (MMAE), via a proprietary enzyme-cleavable linker (AGS-22CE), with potential antineoplastic activity. The monoclonal antibody moiety of enfortumab vedotin selectively binds to nectin-4. After internalization and proteolytic cleavage, MMAE binds to tubulin and inhibits its polymerization, which results in G2\u002FM phase arrest and induces apoptosis in nectin-4 overexpressing tumor cells. Nectin-4, a tumor associated antigen belonging to the nectin family, is overexpressed in a variety of cancers, including breast, bladder, lung and pancreatic cancer.",fdaUniiCode:"DLE8519RWM",identifier:"C114500",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129823","C1512"],synonyms:["AGS 22ME","AGS-22M6E","ASG-22CE","Anti-Nectin 4 ADC ASG-22CE","Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E","ENFORTUMAB VEDOTIN",c,"Enfortumab Vedotin-ejfv","Padcev"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FEnfortumab_Vedotin",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Enfortumab_Vedotin","","Enfortumab Vedotin","2021-10-30T13:18:49.973Z")));